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Retinal Cell Transplantation in the Macula: New 
Techniques 
PETER GOURAS,*:~ PEEP ALGVEREt 
Transplantation of RPE allografts into the submacular space after the removal of neovascular 
membranes in "wet" forms of ARMD usually leads to chronic leakage around the transplant, 
whereas this seldom occurs in transplants in "dry" forms of ARMD. The former may be the result 
of chronic rejection because of a compromised blood/retinal barrier. This is supported by the fact 
that visual function remains over the transplant in the dry forms of ARMD at 6 months after 
transplantation. Whether this function can slow or reverse the progression of ARMD remains to be 
seen. The possibility of transplantation of photoreceptors in retinal degenerations i  also reviewed. 
Copyright © 1996 Elsevier Science Ltd. 
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INTRODUCTION 
We have been attempting to repair the retinal pigmented 
epithelium (RPE) layer in age related macular degenera- 
tion (ARMD). We are assuming that the major cause of 
this degeneration is the result of RPE dysfunction. 
Although this hypothesis, is unproven, there is much to 
indicate that the RPE layer is extremely hard-hit early in 
the course of ARMD (Hogan, 1972; Sarks, 1976; Green, 
1991). If we could reconstruct a healthy new RPE layer in 
the macula of these patients we might have an impact on 
the progressive blindness that ARMD produces and 
perhaps influence the treatment of other forms of macular 
disease. 
In order to do this man,./problems ust be solved. First 
of all are the techniques ~Io move and deliver viable, and 
functional foreign RPE into the subretinal space without 
damaging the host photoreceptors, and placing these cells 
either on top of or displacing and removing the 
degenerate host RPE layer. Second, we have the question 
of host/graft rejection threatening the long-term survival 
of such transplants; although this is probably a lesser 
problem because immunosuppression could be em- 
ployed. It would, however, be valuable to know how 
necessary immunosuppression is. Third, it is also 
necessary to know exactly what macular or retinal 
degenerations are due to a primary defect in the RPE 
layer. 
We have been performing RPE transplantation i
selected patients with ARMD while we carry out parallel 
experiments in animals to test each change in technique 
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before we attempt it in human surgery. We have now 
performed such surgery in 13 patients which can be 
grouped into three categories reflecting successive 
changes and/or improvements in our technique. We 
believe it is essential to do this in the human retina 
because there is no animal model of ARMD and the 
results of this procedure are very dependent upon the 
unique conditions ARMD produces. 
Foveal patch transplants in "wet" ARMD 
The first group of patients had "wet" forms of ARMD. 
All had subfoveal neovascular membranes and were 
candidates for surgical resection of these membranes, a 
technique that can sometimes be beneficial (Thomas & 
Kaplan, 1991; Thomas, 1994). In subfoveal neovascular- 
ization the adjacent RPE layer is invariably involved by 
scarring and therefore tends to be removed by the surgery 
(Lopez et al., 1991; Seregard et al., 1994). Therefore, it is 
reasonable to try to replace this with a new RPE 
monolayer. 
To do this we used a method that can transfer 
monolayer patches of cultured human fetal RPE from 
one culture plate to another (Gouras et al., 1994a). One 
cuts out a small monolayer patch of RPE growing on a 
culture plate, sucks it into a glass micropipette and then 
ejects it into the subretinal space where it tends to unfold 
to form a quasi-monolayer intimately associated with the 
host's photoreceptor layer (Sheng et al., 1994). Immedi- 
ately after the subfoveal neovascular membranes are 
removed, such a patch of cultured human fetal RPE was 
injected into the subretinal space (Algvere et al., 1994). 
Figure 1 illustrates a scanning laser ophthalmoscopic 
(SLO) view of one such transplant at 2 days (A), 1 month 
(B) and 3 months (C) after transplantation. 
Up to 1 month this patient was detecting light and 
foveally fixating over the transplant. At 3 months, 
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FIGURE 1. Fundus photographs of a 69-year-old subject who had 
received an RPE patch transplant a 2 days (A), 1 month (B) and 3 
months (C) after surgery. The transplant appears as a dark patch in a 
lighter background, which delineates the area from which a subfoveal 
neovascular membrane had been removed. The size of the dark 
(pigmented) patch increases with time. The small white dots indicate 
fixation and the symbols (A) indicating visibility or ( ) lack of it, as 
determined by scanning laser ophthalmoscopy. 
however, retinal function over the transplant had 
diminished and fixation had become eccentric. During 
this time leakage of fluorescein slowly developed around 
and over the transplant (Algvere et al., 1994). Only one 
patient did not have leakage but this was the only patient 
in which the transplant was placed adjacent o and not 
directly at the fovea. This patient has maintained almost 
the same visual acuity at 1 yr after transplantation asshe 
had just prior to surgery. The fact that chronic leakage has 
been typical in these transplants uggests that they are 
encountering chronic rejection. 
FIGURE 2. Human fetal RPE in culture. A trephine has cut a circular 
patch 0.6 mm in diameter (A). This patch can be gently rolled off its 
attachments to the culture plate (B) and (C) before being sucked into a 
transplant pipette. 
In prior animal experiments we found no rejection of 
RPE xenografts of cultured fetal human RPE transplants 
to monkey retina at 2-3 months after surgery (Sheng et 
al., 1994). We have since extended these experiments o 
test 21 human RPE transplants in eight monkeys, 16 
transplants in the perimacular region and five directly in 
the fovea (Gouras et al., 1995; Berglin et al., in 
preparation). After 6 months we examined each trans- 
plant histologically, performing quasi-serial sectioning. 
We found evidence of rejection in only 19% (3/16) of the 
perimacular transplants but 60% (3/5) of the foveal 
transplants. We concluded that RPE transplants, even 
xenografts, are not invariably rejected but those in the 
fovea appear to be more prone to rejection. We also 
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observed that all the rejected transplants showed leakage 
but non-rejected ones did not. Therefore the chronic 
leakage manifest in four of the five human RPE 
allografls, all in the fovea, could represent rejection. 
However, it was somewhat surprising that most monkey 
xenografts did not reject whereas most human allografts 
did. We hypothesized that the presence of an intact blood/ 
retinal barrier was important because in the human 
subjects it had been compromised by both neovascular- 
ization and the surgery whereas in the monkey it was not. 
Patch transplants in "drT" ARMD 
In order to examine this experimentally we performed 
RPE transplantation in patients with advanced but "dry" 
forms of ARMD. In these patients no neovascular 
membrane xists and therefore the transplant could be 
introduced into the subretinal space with the blood/retinal 
barrier relatively undisturbed. In order to further mini- 
mize possible host/graft rejection we also reduced the 
size of the transplant. 
In four of these patients we used a circular RPE patch 
transplant, 0.6 mm in diameter. By using circular patches 
there would be less corners to curl up to jeopardize the 
monolayer's flatness. WiSh a circular transplant we would 
know its precise geometry visible in the fundus if it did 
not fold and deviations might provide clues to how 
folding occurs. 
To produce circular RPE patch transplants we 
constructed a set of trephines that could cut out circular 
areas from 0.5 to 1.0 mm in diameter. We chose 0.6 mm 
diameters because these produced small enough patches 
that folded minimally when sucked into the transplant 
pipette and also had a relatively high ratio of untouched 
to trephined cells along its edge. Figure 2 shows a circular 
patch of cultured human fetal RPE trephined and rolled 
off a culture plate before being sucked into a transplant 
pipette (Lavid et al., 1995). 
We have transplanted such patches into four patients 
with advanced but "dr3," ARMD. In order to further 
minimize possible rejectiion, we placed the transplants at 
the edge of the macula, away from the fovea. At 6 months 
after transplantation ly one of four transplants shows 
any evidence of leakage. Because most of these 
transplants how no leakage and all support visual 
function through the adjacent photoreceptors, for now 6 
months after surgery, we are concluding that the presence 
of an intact blood/retinal barrier tends to prevent he 
development of leakage from and probably rejection of 
these transplants. 
We were not satisfied, however, for several reasons. 
The circular transplants are partially folded, appearing 
elliptical rather than circular. Although this does not 
cause the contiguous receptors to degenerate, it is less 
than optimal. In animal experimentation, such photo- 
receptors abutting a multilayered transplant are not as 
long as they are next to an unfolded one. We have 
measured the lengths of outer and inner segments and the 
width of the outer nuclear layer and compared them to the 
width of adjacent RPE transplants in monkeys. The 
thicker the transplant becomes due to folding, the more 
reduced is the width of the overlying photoreceptor layer 
although many photoreceptors, ods and cones, survive 
over multi-layered transplants (Berglin et al., in prepara- 
tion). 
In addition, we have not covered the foveal area which 
we believe to be the most critical to save from the 
destruction of ARMD. We would like to cover the fovea 
but this must be performed as gently as possible because 
we know from monkey experiments hat the foveal area 
appears to be more vulnerable to rejection. 
Cell suspension RPE transplants in "dry" ARMD 
In order to cover the foveal atraumatically with healthy 
RPE we are using concentrated suspensions of partially 
dissociated RPE cells. The dissociation leaves small 
groups of RPE cells, 10-15 together among smaller 
groups of individual cells. 
We used this method before (Gouras et al., 1986; 
Lopez & Gouras, 1987) but have improved tailoring the 
size of the detachment to the volume of the cell 
suspension. This produces a more complete coverage as 
the cells are captured by the reattaching neural retina. 
This method allows a smaller orifice in the transplant 
pipette, about 0.05 mm, compared to 0.2-0.3 mm for 
transplanting a complete RPE patch. The retinotomy is 
smaller and self-seals, preventing any cells from efflux- 
ing into the vitreal chamber. The smaller size and the 
self-sealing action of the retinotomy are advantages that 
facilitate RPE transplantation in the submacular space. 
We have performed such RPE cell suspension 
transplants on four patients with "dry" forms of ARMD. 
The cell suspension spreads across the subretinal space, 
including the fovea. These patients, now 3 months after 
surgery, have the same vision as they had before surgery 
and have no evidence of leakage ven though the fovea 
has been included in the transplant area. 
So far we have performed RPE transplantation i  13 
patients, five with "wet" and eight with "dry" forms of 
ARMD. Most of the former slowly develop chronic 
leakage over the transplant; most of the latter do not. 
Therefore, we believe that rejection seldom occurs with 
RPE allografts to the subretinal space if the blood/retinal 
barrier is intact. If there is no chronic leakage visual 
function is maintained over the transplant, implying that 
the transplants are functioning. Whether such function 
can arrest or reverse the progression of ARMD remains to 
be seen. 
The best analogy is the RCS rat model. If one 
transplants a suspension of healthy RPE cells into the 
subretinal space of the RCS rat (Reppucci et al., 1988) 
before the photoreceptors have degenerated, this degen- 
eration can be prevented (Li & Turner, 1988; Lopez et 
al., 1989; Gouras et al., 1989) essentially for the life of 
the animal (LaVail et al., 1992; Yamamoto et al., 1993). 
A similar strategy may help in ARMD if the RPE cell is 
the major cause of the disease. 
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FIGURE 3. Transgenic LacZ expressing (shaded) photoreceptors that 
have been transplanted into the subretinal space of normal mice 4 (A) 
and 6 (B) months previously. The arrows identify nuclei of host 
photoreceptor cells. 
Photoreceptor transplantation 
Will it be possible to restore visual function to a 
macula that has lost it? This is a difficult question and its 
answer will depend on whether the responder is an 
optimist or a cynic. I shall give the optimistic response. 
Neural retina, especially embryonic tissue, survives 
well when transplanted to a foreign host brain (Lund, 
1991) or retina (Turner & Blair, 1986; del Cerro et al., 
1989; Silverman & Hughes, 1989; Aramant et al., 1990; 
Ehinger et al., 1991; Gouras et al., 1991). These 
transplants are capable of delivering synaptically trans- 
mitted information about light stimulation to the brain 
(Lund, 1991). This has not yet been demonstrated 
unequivocally for intraretinal transplants but the results 
are promising. All attempts to transplant neural retina 
have led to rosette formation. Rosettes are balls of retinal 
cells within which outer segments form centripetally. 
These outer segments can develop reasonably well 
(Ehinger et al., 1991) and mediate responses to light 
(Adolph et al., 1994). These photoreceptors inevitably 
degenerate, however, because they are not in contact with 
the RPE layer and the formation of rosettes is also not 
conducive to effective visual function. 
We have shown that if one uses relatively small 
aggregates of neonatal retina, and the orientation of the 
transplant to the RPE layer is correct which occurs about 
50% of the time, healthy photoreceptors with normal 
FIGURE 4. A transplant of fetal human neural retina to the subretinal 
space of an immunosuppressed rabbit retina at 1 week after surgery. 
The human transplant (H) shows both inner and outer nuclear layer, the 
latter contains both cones (c) and rods (r) which are in close contact 
with the rabbit (R) RPE layer. 
outer segments will form in contiguity with the foreign 
host RPE without rosette formation. These photorecep- 
tors will survive essentially for the life of the animal, a 
mouse (Gouras et al., 1992,b). Figure 3 shows an 
example of transplants at 4(A) and 6(B) months after 
surgery. Cones as well as rods can survive transplanta- 
tion. 
For the human fovea, cones are the critical photo- 
receptors. The only way to learn how to transplant cones 
experimentally is to work with primates, preferably 
human fetal tissue, which has been opened up in the 
U.S.A. by the Clinton administration. It would be 
extremely difficult o do this using fetal monkey tissue. 
Figure 4 shows such a human fetal photoreceptor 
transplant properly oriented to the RPE layer of an 
immunosuppressed host rabbit, 1 month after surgery. 
This was an 18 week old human fetal specimen ow one 
additional month in a foreign host retina. It shows 
numerous human cones as well as rods surviving well and 
oriented correctly. Very little outer segment material has 
yet developed but the appearance ofthese cones and rods 
is promising (Linet al., 1995). One has to temper this 
optimistic view of photoreceptor transplantation with the 
sober reality that it is an extraordinarily difficult feat. 
Many hurdles face the experimenter, gliosis, mechanical 
fragility of the tissue, cone alignment and synaptic 
precision that defies current microsurgical technology. It 
also defies the more cautious views of funding agencies 
so necessary to support such research. In addition, 
unjustified exaggeration gives false hopes to the blind. 
Nevertheless the concept is rational, perhaps like an 
Archimedean dream of moving the earth with a big 
enough stick. Here it is more like moving a cone if you 
had a small enough stick. 
CONCLUSION 
We have shown that it is possible to begin reconstruct- 
ing the human macula from the ground up, i.e., from the 
RPE layer inward. The RPE layer is the most tractable 
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because it is non-neural and functions merely by close 
apposition with the photoreceptors. It is also possible to 
transplant photoreceptors by placing them in the proper 
orientation in the subretinal space, where they survive 
indefinitely. Therefore, the building blocks for recon- 
structing the outer retinal layers are viable and functional 
as transplants. Whether it will actually restore vision to a 
blind retina remains to be seen. 
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